Assembly Biosciences - 53 Year Dividend History | ASMB
Historical dividend payout and yield for Assembly Biosciences (ASMB) since 1971. The current TTM dividend payout for Assembly Biosciences (ASMB) as of October 31, 2024 is $0.00. The current dividend yield for Assembly Biosciences as of October 31, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.107B |
$0.007B |
|
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
